5433.0000 -75.00 (-1.36%)
NSE Sep 26, 2025 15:31 PM
Volume: 181.5K
 

5433.00
-1.36%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended